Intrathecal Tetanus Immunoglobulin to Treat Tetanus
Learn more about:
Related Clinical Trial
Double Blind, Randomized Phase III Study to Evaluate the Immunogenicity and Safety of ‘BR-TD-1001’ Administered Intramuscularly in Healthy Children
Safety and Immunogenicity Study of Influenza Vaccines in HIV-infected and HIV-uninfected Pregnant Women in Western Kenya
The Role of the Intestinal Microbiome in Enteric and Systemic Vaccine Immune Responses
REVAXIS® Versus DT Polio® as a Second Booster in 6 Year-old Children
Tdap Vaccine Safety for Plasma Donors
Antitetanus Vaccination for People Older Than 65 Years.
Multicenter Study of Tetanus Patients in Fujian Province of China
The Change of the Tetanus Antibody Titer After Single Injection of Td and Simultaneous Injection of TIG With Td
Immunogenicity and Safety of a Tetanus-diphtheria Vaccine and a 13-valent Pneumococcal Conjugate Vaccine
Pneumonia in Tetanus Study
Intrathecal Tetanus Immunoglobulin to Treat Tetanus
Canadian Manufactured Tetanus and Diphtheria Toxoids Adsorbed (Td) Vaccine Compared With U.S. Manufactured Td
Comparative Study of Two Tetanus Toxoid Vaccination Strategies: Cold Chain Versus Controlled Temperature Chain
Tetanus Immunization in Subjects With No Immunization History or With Tetanus Antibody Levels Below Protective Levels